000 01496 a2200421 4500
005 20250517173907.0
264 0 _c20181126
008 201811s 0 0 eng d
022 _a1573-2509
024 7 _a10.1016/j.schres.2017.09.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchjerning, Ole
245 0 0 _aPregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.
_h[electronic resource]
260 _bSchizophrenia research
_c05 2018
300 _a260-266 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Anxiety Agents
_xtherapeutic use
650 0 4 _aAnxiety
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuropsychological Tests
650 0 4 _aPregabalin
_xtherapeutic use
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aSchizophrenia
_xcomplications
650 0 4 _aSchizophrenic Psychology
650 0 4 _aSurveys and Questionnaires
650 0 4 _aTreatment Outcome
700 1 _aDamkier, Per
700 1 _aLykkegaard, Signe Engelhardt
700 1 _aJakobsen, Klaus Damgaard
700 1 _aNielsen, Jimmi
773 0 _tSchizophrenia research
_gvol. 195
_gp. 260-266
856 4 0 _uhttps://doi.org/10.1016/j.schres.2017.09.014
_zAvailable from publisher's website
999 _c27573809
_d27573809